Clonal Evolution Of Aplastic Anaemia To Myelodysplasia/Acute Myeloid Leukaemia and Paroxysmal Nocturnal Haemoglobinuria

References

• Camitta B. M., Thomas E. D., Nathan D. G., Santos G., Gordon‐Smith E. C., Gale R. P., Rappeport J. M., Storb R. Severe aplastic anemia: A prospective study of the effect of early marrow transplantation on acute mortality. Blood 1976; 48: 63–70
   PubMed Web of Science ®Google Scholar
• Bacigalupo A., Hows J., Gluckman E., Nissen C., Marsh J., Van Lint M. T., Congiu M., De Planque M. M., Ernst P., McCann S., Ragavashar A., Frickhofen N., Wursch A. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA Working Party. Br. J. Haematol. 1988; 70: 177–182
   PubMed Web of Science ®Google Scholar
• Marsh J. C. W., Chang J., Testa N. G., Hows J. M., Dexter T. M. The hematopoietic defect in aplastic anemia assessed by long‐term marrow culture. Blood 1990; 76: 1748–1757
   PubMed Web of Science ®Google Scholar
• Scopes J., Daly S., Atkinson R., Ball S. E., Gordon‐Smith E. C., Gibson F. M. Aplastic anemia: Evidence for dysfunctional bone marrow progenitor cells and the corrective effect of granulocyte colony‐stimulating factor in vitro. Blood 1996; 87: 3179–3185
   PubMed Web of Science ®Google Scholar
• Scopes J., Bagnara M., Gordon‐Smith E. C., Ball S. E., Gibson F. M. Haemopoietic progenitor cells are reduced in aplastic anaemia. Br. J. Haematol. 1994; 86: 427–430
   PubMed Web of Science ®Google Scholar
• Marsh J. C. W., Chang J., Testa N. G., Hows J. M., Dexter T. M. In vitro assessment of marrow “stem cell” and stromal cell function in aplastic anaemia. Br. J. Haematol. 1991; 78: 258–267
   PubMed Web of Science ®Google Scholar
• Maciejewski J. P., Selleri J. P., Sato T., Anderson S., Young N. S. A severe and consistent deficit in bone marrow and circulating primitive hematopoietic cells (long‐term‐culture‐initiating cells) in acquired aplastic anemia. Blood 1996; 88: 1983–1991
   PubMed Web of Science ®Google Scholar
• Schrezenmeier H., Jenal M., Herrmann F., Heimpel H., Raghavachar A. Quantitative analysis of cobblestone area‐forming cells in bone marrow of patients with aplastic anemia by limiting dilution assay. Blood 1996; 88: 4474–4480
   PubMed Web of Science ®Google Scholar
• Zoumbos N. C., Gascón P., Djeu J., Trost S. R., Young N. S. Circulating activated suppressor T lymphocytes in aplastic anemia. N. Engl. J. Med. 1985; 312: 257–265
   PubMed Web of Science ®Google Scholar
• Maciejewski J. P., Hibbs J. R., Anderson S., Katevas P., Young N. S. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp. Hematol. 1994; 22: 1102–1110
   PubMed Web of Science ®Google Scholar
• Philpott N. J., Scopes J., Marsh J. C. W., Gordon‐Smith E. C., Gibson F. M. Increased apoptosis in aplastic anemia bone marrow progenitor cells: Possible pathophysiologic significance. Exp. Hematol. 1995; 23: 1642–1648
   PubMed Web of Science ®Google Scholar
• Maciejewski J. P., Selleri C., Sato T., Anderson S., Young N. S. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br. J. Haematol. 1995; 91: 245–252
   PubMed Web of Science ®Google Scholar
• Maciejewski J. P., Selleri C., Anderson S., Young N. S. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine‐mediated hematopoietic suppression in vitro. Blood 1995; 85: 3183–3190
   PubMed Web of Science ®Google Scholar
• Appelbaum F. R., Barrall J., Storb R., Ramberg R., Doney K., Sale G. E., Thomas E. D. Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp. Hematol. 1987; 15: 1134–1139
   PubMed Web of Science ®Google Scholar
• de Planque M. M., Brand A., Kluin‐Nelemans H. C., Eerinesse J. G., van der Burgh F., Natarajan A. T., Beverstock G. C., Zwaan F. E., Willemze R., van Rood J. J. Haematopoietic and immunologic abnormalities in severe aplastic anaemia patients treated with anti‐thymocyte globulin. Br. J. Haematol. 1989; 71: 421–430
   PubMed Web of Science ®Google Scholar
• Tichelü A., Gratwohl A., Nissen C., Speck B. Late clonal complications in severe aplastic anemia. Leuk. and Lymph. 1994; 12: 167–175
   PubMed Web of Science ®Google Scholar
• Moormeier J. A., Rubin C. M., Le Beau M. M., Vardiman J. W., Larson R. A., Winter J. N. Trisomy 6: a recurring cytogenetic abnormality associated with marrow hypoplasia. Blood 1991; 77: 1397–1398
   PubMed Web of Science ®Google Scholar
• Barrios N. J., Kirkpatrick D. V., Levin M. L., Varela M. Transient expression of trisomy 21 and monosomy 7 following cyclosporin A in a patient with aplastic anemia. Leuk. Res. 1991; 15: 531–533
   PubMed Web of Science ®Google Scholar
• Molldrem J. J., Caples M., Mavroudis D., Plante M., Young N. S., Barrett A. J. Antithymocyte globulin for patients with myelodysplastic syndrome. Br. J. Haematol. 1997; 99: 699–705
   PubMed Web of Science ®Google Scholar
• Josten K. M., Tooze J. A., Borthwick‐Clarke C., Gordon‐Smith E. C., Rutherford T. R. Acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria: studies on clonality. Blood 1991; 78: 3162–3167
   PubMed Web of Science ®Google Scholar
• Raghavachar A., Janssen J. W. G., Schrezenmeier H., Wagner B., Bartram C. R., Schulz A. S., Hein C., Cowling G., Mubarik A., Testa N. G., Dexter T. M., Hows J. M., Marsh J. C. W. Clonal hemato‐poiesis as defined by polymorphic X‐linked loci occurs infrequently in aplastic anemia. Blood 1995; 86: 2938–2947
   PubMed Web of Science ®Google Scholar
• Anan K., Ito M., Misawa M., Ohe Y., Kai S., Kohsaki M., Hara H. Clonal analysis of peripheral blood and haemopoietic colonies in patients with aplastic anaemia and refractory anaemia using the polymorphic short tandem repeat on the human androgen‐receptor (HUMARA) gene. Br. J. Haematol. 1995; 89: 838–844
   PubMed Web of Science ®Google Scholar
• van Kamp H., Landegènt J. E., Jansen R. P. M., Willemze R., Fibbe W. E. Clonal hematopoiesis in patients with acquired aplastic anemia. Blood 1991; 78: 3209–3214
   PubMed Web of Science ®Google Scholar
• Melenhorst J. J., Fibbe W. E., Struyk L., van der Elsen P. J. Analysis of T‐cell clonality in bone marrow of patients with acquired aplastic anaemia. Br. J. Haematol. 1997; 96: 85–91
   PubMed Web of Science ®Google Scholar
• Mathé G., Amiel J. L., Schwarzenberg L., Choay J., Trolard P., Schneider M., Hayat M., Schlumberger J. R., Jasmin C. Bone marrow graft in man after conditioning by antilymphocyte serum. Br. Med. J. 1970; 2: 131–136
   PubMed Web of Science ®Google Scholar
• Young N., Griffith P., Brittain E., Elfenbein G., Gardner F., Huang A., Harmon D., Hewlett J., Fay J., Mangen K., Morrison F., Sensenbrenner L., Shadduck R., Wang W., Zaroulis C., Zuckerman K. A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood 1988; 72: 1861–1869
   PubMed Web of Science ®Google Scholar
• Gluckman E., Esperou‐Bourdeau H., Baruchel A., Boogaerts M., Briere J., Donadio D., Leverger G., Leporrier M., Reiffers J., Janvier M., Michallet M., Strychmans P., Cooperative Group on the Treatment of Aplastic Anemia. Multicenter randomized study comparing cyclosporine‐A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood 1992; 79: 2540–2546
   PubMed Web of Science ®Google Scholar
• Crump M., Larratt L. M., Maki E., Curtis J. E., Minden M. D., Meharchand J. M., Lipton J. H., Messner H. Treatment of adults with severe aplastic anemia: Primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation. Am. J. Med. 1992; 92: 596–602
   PubMed Web of Science ®Google Scholar
• Marsh C. W., Gordon‐Smith E. C. Treatment of aplastic anaemia with antilymphocyte globulin and cyclosporin. Int. J. Hematol. 1995; 62: 133–144
   PubMed Web of Science ®Google Scholar
• Young N. S., Barrett A. J. The treatment of severe acquired aplastic anemia. Blood 1995; 85: 3367–3377
   PubMed Web of Science ®Google Scholar
• Young N. S. Aplastic anemia. Lancet 1995; 346: 228–232
   PubMed Web of Science ®Google Scholar
• Rebellato L. M., Gross U., Verbanac K. M., Thomas J. M. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Tranpl. 1994; 57: 685–694
   PubMed Web of Science ®Google Scholar
• Teramura M., Kobayashi S., Iwabe K., Yoshinaga K., Mizoguchi H. Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism. Br. J. Haematol. 1997; 96: 80–84
   PubMed Web of Science ®Google Scholar
• Di Padova F. E. Pharmacology of cyclosporine (Sandimmune) V. Pharmacological effects on immune function: In vitro studies. Pharmacol. Rev. 1989; 41: 373–405
   Web of Science ®Google Scholar
• Ryffell B. Phamacology of cyclosporine. VI. Cellular activation: regulation of intracellular events by cyclosporine. Pharmacol. Rev. 1989; 41: 407–422
   Web of Science ®Google Scholar
• Rosenfeld S. J., Kimball J., Vining D., Young N. S. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995; 85: 3058–3065
   PubMed Web of Science ®Google Scholar
• Bacigalupo A., Broccia G., Corda G., Arcese W., Carotenuto M., Gallamini A., Locatelli F., Mori P. G., Saracco P., Todeschini G., Coser P., Iacopino P., van Lint M. T., Gluckman E., European Group for Blood and Marrow Transplantation (EBMT) Working Party on S. A. A. Antilymphocyte globulin, cyclosporin, and granulocyte colony‐stimulating factor in patients with acquired severe aplastic anemia (SAA): A pilot study of the EBMT SAA Working Party. Blood 1995; 85: 1348–1353
   PubMed Web of Science ®Google Scholar
• Tichelli A., Gratwohl A., Würsch A., Nissen C., Speck B. Late haematological complications in severe aplastic anaemia. Br. J. Haematol. 1988; 69: 413–418
   PubMed Web of Science ®Google Scholar
• Socié G., Henry‐Amar M., Bacigalupo A., Hows J., Tichelli A., Ljungman P., McCann S., Frickhofen N., Van't Veer‐Korthof E., Gluckman E., European Bone Marrow Transplantation‐Severe Aplastic Anaemia Working Party. Malignant tumors occurring after treatment of aplastic anemia. N. Engl. J. Med. 1993; 329: 1152–1157
   PubMed Web of Science ®Google Scholar
• Crosby W. H. Paroxysmal nocturnal hemoglobinuria. A classic description by Paul Strübing in 1882, and a bibliography of the disease. Blood 1951; 6: 270–284
   PubMed Web of Science ®Google Scholar
• Dacie J. V. Paroxysmal nocturnal haemoglobinuria. Proc. R. Soc. Med. 1963; 56: 587–596
   PubMedGoogle Scholar
• Dacie J. V., Lewis S. M. Laboratory methods used in the investigation of paroxysmal nocturnal haemoglobinuria (PNH). Practical Haematologyeighth edition, L. Luzzatto, P. Hillmen. Churchill Livingstone, Edinburgh 1995; 287–296
   Google Scholar
• Socié G., Mary J. ‐Y., de Gramont A., Rio B., Leporrier M., Rose C., Heudier P., Rochant H., Cahn J. ‐Y., Gluckman E., French Society of Haematology. Paroxysmal nocturnal haemoglobinuria: long term follow‐up and prognostic factors. Lancet 1996; 348: 573–577
   PubMed Web of Science ®Google Scholar
• Hillmen P., Lewis S. M., Bessler M., Luzzatto L., Dacie J. V. Natural history of paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 1995; 333: 1253–1258
   PubMed Web of Science ®Google Scholar
• Oni S. B., Osunkoya B. O., Luzzatto L. Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells. Blood 1970; 36: 145–152
   PubMed Web of Science ®Google Scholar
• Bessler M., Mason P. J., Hillmen P., Miyata T., Yamada N., Takeda J., Luzzatto L., Kinoshita T. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG‐A gene. EMBO Journal 1994; 13: 110–117
   PubMed Web of Science ®Google Scholar
• Miyata T., Yamada N., Iida Y., Nishimura J., Takeda J., Kitani T., Kinoshita T. Abnormalities of PIG‐A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 1994; 330: 249–255
   PubMed Web of Science ®Google Scholar
• Ware R. E., Rosse W. F., Howard T. A. Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria. Blood 1994; 83: 2418–2422
   PubMed Web of Science ®Google Scholar
• Yamada N., Miyata T., Maeda K., Kitani T., Takeda J., Kinoshita T. Somatic mutations of the PIG‐A Gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 1995; 85: 885–892
   PubMed Web of Science ®Google Scholar
• Dacie J. V., Lewis S. M. Paroxysmal nocturnal haemoglobinuria: Clinical manifestations, haematology, and nature of the disease. Series Haematologica 1972; V.: 3–23
   Google Scholar
• Takeda J., Miyata T., Kawagoe K., Iida Y., Endo Y., Fujita T., Takahashi M., Kitani T., Kinoshita T. Deficiency of the GPI anchor caused by a somatic mutation of the PIG‐A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993; 73: 703–711
   PubMed Web of Science ®Google Scholar
• Miyata T., Takeda J., Iida Y., Yamada N., Inoue N., Takahashi M., Maeda K., Kitani T., Kinoshita T. The cloning of PIG‐A, a component in the early step of GPI‐anchor biosynthesis. Science 1993; 259: 1318–1320
   PubMed Web of Science ®Google Scholar
• Armstrong C., Schubert J., Ueda E., Knez J. J., Gelperin D., Hirose S., Silber R., Hollan S., Schmidt R. E., Medof M. E. Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N‐acetyl‐D‐glucosamine inositol phospholipid corresponding to that in class A Thy‐1 murine lymphoma mutants. J. Biol. Chem. 1992; 267: 25347–25351
   PubMed Web of Science ®Google Scholar
• Hillmen P., Bessler M., Mason P. J., Watkins W. M., Luzzatto L. Specific defect in N‐acetylglucosamine incorporation in the biosynthesis of the glycosylphosphati‐dylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc. Natl. Acad. Sci. USA. 1993; 90: 5272–5276
   PubMed Web of Science ®Google Scholar
• Rosse W. F., Ware R. E. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood 1995; 86: 3277–3286
   PubMed Web of Science ®Google Scholar
• Lachmann P. J. The control of homologous lysis. Immunol. Today 1991; 12: 312–315
   PubMedGoogle Scholar
• Rosse W. F., Parker C. J. Paroxysmal nocturnal haemoglobinuria. Clin. Haematol. 1985; 14: 105–125
   PubMedGoogle Scholar
• Holguin M. H., Frederick L. R., Bernshaw L. A., Wilcox L. A., Parker C. J. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J. Clin. Invest. 1989; 84: 7–17
   PubMed Web of Science ®Google Scholar
• Yamashina M., Ueda E., Kinoshita T., Takami T., Ojima A., Ono H., Tanaka H., Kondo N., Orii T., Okada N., Okada H., Inoue K., Kitani T. Inherited complete deficiency of 20‐kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 1990; 323: 1184–1189
   PubMed Web of Science ®Google Scholar
• Lublin D. M., Atkinson J. P. Decay‐accelerating factor: biochemistry, molecular biology, and function. Annual Review of Immunology 1989; 7: 35–58
   PubMed Web of Science ®Google Scholar
• Nicholson‐Weller A., Spicer D. B., Austen K. F. Deficiency of the complement regulatory protein, “decay‐accelerating factor”, on membranes of granulocytes, monocytes, and platelets in paroxysmal nocturnal hemoglobinuria. N. Engl. J. Med. 1985; 312: 1091–1097
   PubMed Web of Science ®Google Scholar
• Fujita T., Inoue T., Ogawa K., Iida K., Tamura N. The mechanism of action of decay‐accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. J. Exp. Med. 1987; 166: 1221–1227
   PubMed Web of Science ®Google Scholar
• Lin L., Liu C., Chen Y., Shen M., Wang C., Huang Y., Lin J. PIG‐A gene mutations in four Taiwanese patients with paroxysmal nocturnal haemoglobinuria following aplastic anaemia. Br. J. Haematol. 1997; 97: 286–292
   PubMed Web of Science ®Google Scholar
• van der Schoot C. E., Huizinga T. W. J., van't Veer‐Korthof E. T., Wijmans R., Pinkster J., von dem Borne A. E.G. K. Deficiency of glycosylphos‐phatidylinositol‐linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay. Blood 1990; 76: 1853–1859
   PubMed Web of Science ®Google Scholar
• Schubert J., Alvarado M., Uciechowski P., Zielin‐ska‐Skowronek M., Freund M., Vogt H., Schmidt R. E. Diagnosis of paroxysmal nocturnal haemoglobinuria using immunophenotyping of peripheral blood cells. Br. J. Haematol. 1991; 79: 487–492
   PubMed Web of Science ®Google Scholar
• Tooze J. A., Saso R., Marsh J. C. W., Papadopoulos A., Pulford K., Gordon‐Smith E. C. The novel monoclonal antibody By 114 helps detect the early emergence of a paroxysmal nocturnal hemoglobinuria clone in aplastic anemia. Exp. Hematol. 1995; 23: 1484–1491
   PubMed Web of Science ®Google Scholar
• Hall S. E., Rosse W. E. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 1996; 87: 5332–5340
   PubMed Web of Science ®Google Scholar
• Vu T., Griscelli‐Bennaceur A., Gluckman E., Sigaux F., Carosella E. D., Menier C., Scrobohaci M. L., Socié G. Aplastic anaemia and paroxysmal nocturnal haemoglobinuria: a study of the GPI‐anchored proteins on human platelets. Br. J. Haematol. 1996; 93: 586–589
   PubMed Web of Science ®Google Scholar
• Jin J. ‐Y., Tooze J. A., Marsh J. C. W., Gordon‐Smith E. C. Glycosylphosphatidylinositol (GPI) linked protein deficiency on the platelets of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria: two distinct patterns correlating with expression on neutrophils. Br. J. Haematol. 1997; 96: 493–496
   PubMed Web of Science ®Google Scholar
• Terstappen L. W.M. M., Nguyen M., Huang S., Lazarus H. M., Medof M. E. Defective and normal haematopoietic stem cells in paroxysmal nocturnal haemoglobinuria. Br. J. Haematol. 1993; 84: 504–514
   PubMed Web of Science ®Google Scholar
• Schrezenmeier H., Hertenstein B., Wagner B., Raghavachar A., Heimpel H. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins. Exp. Hematol. 1995; 23: 81–87
   PubMed Web of Science ®Google Scholar
• Fujioka S., Yamada T. Decay‐accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia. Br. J. Haematol. 1993; 83: 660–662
   PubMed Web of Science ®Google Scholar
• Rosse W. F. Paroxysmal nocturnal haemoglobinuria in aplastic anaemia. Clin. Haematol. 1978; 7: 541–553
   PubMedGoogle Scholar
• Letman H. Possible paroxysmal nocturnal hemoglobinuria with pronounced pancytopenia, reticulocytopenia, and without hemoglobinuria simulating aplastic anemia. Blood 1952; 7: 842–849
   PubMed Web of Science ®Google Scholar
• Kruatrachue M., Wasi P., Na‐Nakom S. Paroxysmal nocturnal haemoglobinuria in Thailand with special reference to an association with aplastic anaemia. Br. J. Haematol. 1978; 39: 267–276
   PubMed Web of Science ®Google Scholar
• Stoppa A. M.N. V., Sainty D., Amoulet C., Camerlo J., Cappiello M. A., Gastaut J. A., Maraninchi D. Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administration. Br. J. Haematol. 1996; 93: 42–44
   PubMed Web of Science ®Google Scholar
• Rotoli B., Robledo R., Luzzatto L. Decreased number of circulating BFU‐Es in paroxysmal nocturnal hemoglobinuria. Blood 1982; 60: 157–159
   PubMed Web of Science ®Google Scholar
• Moore J. G., Humphries R. K., Frank M. M., Young N. Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria. Exp. Hematol. 1986; 14: 222–229
   PubMed Web of Science ®Google Scholar
• Lewis S. M., Dacie I. V. The aplastic anaemia‐paroxysmal nocturnal haemoglobinuria syndrome. Br. J. Haematol. 1967; 13: 236–251
   PubMed Web of Science ®Google Scholar
• Bessler M., Mason P., Hillmen P., Luzzatto L. Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet 1994; 343: 951–953
   PubMed Web of Science ®Google Scholar
• Wanachiwanawin W., Pattanapanyasat K. Emerging of DAF‐negative erythrocyte clone in aplastic anaemia before and during haematologic recovery. Br. J. Haematol. 1991; 79: 123–124
   PubMed Web of Science ®Google Scholar
• Rotoli B., Bessler M., Alfinito F., del Vecchio L. Membrane proteins in paroxysmal nocturnal haemoglobinuria. Blood Rev. 1993; 7: 75–86
   PubMed Web of Science ®Google Scholar
• Endo M., Beatty P. G., Vreeke T. M., Wittwer C. T., Singh S. P., Parker C. J. Syngeneic bone marrow transplantation without conditioning in a patient with paroxysmal nocturnal hemoglobinuria: In vivo evidence that the mutant stem cells have a survival advantage. Blood 1996; 88: 742–750
   PubMed Web of Science ®Google Scholar
• Maciejewski J. P., Sloand E. M., Sato T., Anderson S., Young N. S. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphstidylinoditol‐anchored protein‐deficient clone. Blood 1997; 89: 1173–1181
   PubMed Web of Science ®Google Scholar
• Nagarajan S., Brodsky R. A., Young N. S., Medof M. E. Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood 1995; 86: 4656–4661
   PubMed Web of Science ®Google Scholar
• De Lord C., Tooze J. A., Saso R., Marsh J. C. W., Gordon‐Smith E. C. Deficiency of glycosylphos‐phatidylinositol‐anchored proteins in patients with aplastic anaemia does not affect response to immunosuppressive therapy. Br. J. Haematol. 1998; 101: 90–93
   PubMed Web of Science ®Google Scholar
• Nand S., Godwin J. E. Hypoplastic myelodys‐plastic syndrome. Cancer 1988; 62: 958–964
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C., The French‐American‐British (FAB) Co‐operative Group. Proposals for the classification of the myelodysplas‐tic syndromes. Br. J. Haematol. 1986; 51: 189–199
   Web of Science ®Google Scholar
• Geary C. G., Marsh J. C. W., Gordon‐Smith E. C. Hypoplastic myelodysplasia (MDS). Br. J. Haematol. 1996; 94: 582–583, Letter
   PubMed Web of Science ®Google Scholar
• Tuzuner N., Cox C., Rowe J. M., Watrous D., Bennett J. M. Hypocellular myelodysplastic syndromes (MDS): new proposals. Br. J. Haematol. 1995; 91: 612–617
   PubMed Web of Science ®Google Scholar
• de Greef G. E., Hagemeijer A. Molecular and cytogenetic abnormalities in acute myeloid leukaemia and myelodysplastic syndromes. Baillière's Clin. Haematol. 1996; 9: 1–18
   PubMed Web of Science ®Google Scholar
• Geary C. G., Harrison C. J., Philpott N. J., Hows J. M., Gordon‐Smith E. C., Marsh J. C. W. Abnormal cytogeneic clone in patients with aplastic anaemia: response to immunosuppressive therapy. Br. J. Haematol. 1998, in press
   Web of Science ®Google Scholar
• Haase D., Fonatsch C., Freund M. Karyotype instability in myelodysplastic syndromes—a specific step in pathogenesis preceding clonal chromosome anomolies. Leuk. and Lymph. 1992; 8: 221–228
   PubMed Web of Science ®Google Scholar
• Ball S. E., Gibson F. M., Rizzo S., Tooze J. A., Marsh J. C. W., Gordon‐Smith E. C. Progressive telomere shortening in aplastic anemia. Blood 1998; 91: 3582–3592
   PubMed Web of Science ®Google Scholar
• Holden D., Lichtman H. Paroxysmal nocturnal hemoglobinuria with acute leukemia. Blood 1969; 33: 283–286
   PubMed Web of Science ®Google Scholar
• Kaufmann R. W., Schechter G. P., McFarland W. Paroxysmal nocturnal hemoglobinuria terminating in acute granulocytic leukemia. Blood 1969; 33: 287–291
   PubMed Web of Science ®Google Scholar
• Krause J. R. Paroxysmal nocturnal hemoglobinuria and acute non‐lymphocytic leukemia. A report of three cases exhibiting different cytologic types. Cancer 1983; 51: 2078–2082
   PubMed Web of Science ®Google Scholar
• Devine D. V., Gluck W. L., Rosse W. F., Weinberg J. B. Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone. J. Clin. Invest. 1987; 79: 314–317
   PubMed Web of Science ®Google Scholar
• Longo L., Bessler M., Beris P., Swirsky D., Luzzatto L. Myelodysplasia in a patient with pre‐existing paroxysmal nocturnal haemoglobinuria: a clonal disease originating from within a clonal disease. Br. J. Haematol. 1994; 87: 401–403
   PubMed Web of Science ®Google Scholar
• van Kamp H., Smit J. W., van den Berg E., Halie M. R., Vellenga E. Myelodysplasia following paroxysmal nocturnal haemoglobinuria: evidence for the emergence of a separate clone. Br. J. Haematol. 1994; 87: 399–400
   PubMed Web of Science ®Google Scholar
• Jin J. ‐Y., Tooze J. A., Marsh J. C. W., Matthey F., Gordon‐Smith E. C. Myelodysplasia following aplastic anaemia‐paroxysmal nocturnal haemoglobinuria syndrome after treatment with immunosuppression and G‐CSF: evidence for the emergence of a separate clone. Br. J. Haematol. 1996; 94: 510–512
   PubMed Web of Science ®Google Scholar
• Yasuda M., Shiokawa S., Yamaguchi M., Suenaga Y., Wada T., Nonaka S., Nobunaga M. Trilineage response to rhG‐CSF with subsequent clonal hematopoiesis in a patient with severe bone marrow aplasia. Leuk. and Lymph. 1994; 14: 347–351
   PubMed Web of Science ®Google Scholar
• Izumi T., Muroi K., Takatoku M. ‐A., Imagawa S., Hatake K., Miura Y. Development of acute myeloblasts leukaemia in a case of aplastic anaemia treated with granulocyte colony‐stimulating factor. Br. J. Haematol. 1994; 87: 666–668
   PubMed Web of Science ®Google Scholar
• Imashuku S., Hibi S., Kataoka‐Morimoto Y., Yoshihara T., Ikushima S., Morioka Y., Todo S. Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia following G‐CSF administration. Br. J. Haematol. 1995; 89: 188–190
   PubMed Web of Science ®Google Scholar